Stock listing

LSE:0R1B Biogen Inc. Share Price

UK listing (LSE) of Biogen Inc. · home listing NASDAQ:BIIB

Follow Biogen Inc. into a list and get an email when it puts out news.

Share price · LSE:0R1B

$252.94 USD +2.17 (+0.9%)

Close on Oct 27, 2026

Day range
$248.00 – $255.00 USDOct 27, 2026
Volume
5,204 sharesOct 27, 2026
Market cap
$35.07B USDAt the close on Oct 27, 2026 · price × 138.6M shares outstanding
Biogen Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BIIB · Home$253.62 USD+3.97 (+1.6%)1,303,235$255.39$258.73$251.19$249.65Close on Oct 30, 2026
BMV:BIIB$4,689.60 MXN—50$4,689.60$4,689.60$4,689.60—Close on Oct 27, 2026
LSE:0R1B$252.94 USD+2.17 (+0.9%)5,204$249.67$255.00$248.00$250.77Close on Oct 27, 2026
Frankfurt:IDP€229.90 EUR+4.40 (+2.0%)—€220.55€229.90€220.55€225.50Close on Oct 30, 2026
B3:BIIB34193.80 BRL—27193.80193.80193.80—Close on Oct 14, 2026
Hamburg:IDP€228.25 EUR+2.75 (+1.2%)—€222.25€228.25€221.60€225.50Close on Oct 30, 2026
Munich:IDP€225.60 EUR-0.80 (-0.4%)—€225.55€225.60€225.55€226.40Close on Oct 27, 2026
Dusseldorf:IDP€226.60 EUR+0.40 (+0.2%)—€221.85€226.85€221.20€226.20Close on Oct 30, 2026
Ticker
LSE:0R1B
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LSE
Currency
USD

What changed lately

Calls

Replays

  • Biogen (NASDAQ:BIIB) Q3 2026 Earnings Call

    Wed, Oct 28, 2026 · 8:30 AM ET

    Watch Transcript

  • Biogen (NASDAQ:BIIB) Q2 2026 Earnings Call

    Wed, Jul 29, 2026 · 8:30 AM ET

    Watch Transcript

  • Biogen (NASDAQ:BIIB) Q1 2026 Earnings Call

    Wed, Apr 29, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026

Oct 29, 2026

Q3 2026 Biogen Earnings Presentation

Oct 28, 2026

Biogen Reports Third Quarter 2026 Results

Oct 28, 2026

Biogen Canada Provides Update on CDA Draft Recommendation Supporting Expanded Public Reimbursement of SPINRAZA™ for Canadians with SMA

Oct 26, 2026

Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week

Oct 19, 2026

Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus

Oct 2, 2026

Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN

Sep 17, 2026

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease

Sep 16, 2026

LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China

Sep 3, 2026

Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease

Aug 31, 2026

All Biogen Inc. news

Decks

Biogen Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
77 in the last 12 months · 240 in all · newest Oct 29, 2026 · oldest 2021
Calls
27 calls with a replay · 27 with a transcript · latest Oct 28, 2026
Decks
53 decks · latest Jul 29, 2026

Where Biogen Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BIIB · Home listingNASDAQUnited StatesUSD
gettex:IDPgettexGermanyEUR
BCBA:BIIBBCBAArgentinaARS
Tradegate:IDPTradegateGermanyEUR
LS Exchange:789617LS ExchangeGermanyEUR
BMV:BIIBBMVMexicoMXN
BCBA:BIIBDBCBAArgentinaUSD
Lang & Schwarz:789617Lang & SchwarzGermanyEUR
BCS:BIIBBCSChileUSD
LSE:0R1B · This pageLSEUnited KingdomUSD
Frankfurt:IDPFrankfurtGermanyEUR
Milan:1BIIBMilanItalyEUR
B3:BIIB34B3BrazilBRL
BOATS:BIIBBOATSUnited StatesUSD
Stuttgart:IDPStuttgartGermanyEUR
BIVA:BIIBBIVAMexicoMXN
Hamburg:IDPHamburgGermanyEUR
SIX Swiss:BIIB.USDSIX SwissSwitzerlandUSD
Munich:IDPMunichGermanyEUR
VIE:BIIBViennaAustriaEUR
Dusseldorf:IDPDusseldorfGermanyEUR
Hanover:IDPHanoverGermanyEUR
SIX Swiss:BIIBSIX SwissSwitzerlandCHF
BCS:BIIBCLBCSChileCLP
Turquoise:BIIBNTurquoiseUnited KingdomUSD
BCBA:BIIBCBCBAArgentinaUSD
EUROTLX:4BIIBEUROTLXItalyEUR
BX Swiss:IDPBX SwissSwitzerlandCHF
BCBA:BIIB.CIBCBAArgentinaARS
Xetra:IDPXetraGermanyEUR

Log in to ask 6ix AI your own questions about Biogen Inc.